The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
Recent Progresses in Phototherapy‐Synergized Cancer Immunotherapy
Open accessAbstract
Cancer immunotherapy has recently gained much attention in the search of cancer cure due to its ability to “train” the immune system in seeking out and removing residual tumor cells. However, relying on cancer immunotherapy alone may fail to ablate primary tumors. Phototherapy is a promising modality that offers an elegant solution to eradicate tumors through the simple application of light irradiation and meanwhile triggers immune responses by immunogenic cell death to enhance antitumor immunity. Uniting phototherapy with cancer immunotherapy has been found to achieve synergistic outcomes, promote cancer regression, and even attain immunologic memory. This review summarizes the recent studies on utilizing phototherapy and immunotherapy combinatorial approaches to treat cancer. A variety of nanoplatforms have been investigated in combination with immunoadjuvants and immune checkpoint blockades such as CTLA4 and PD‐L1 pathways. Higher levels of proinflammatory cytokines, improved migration of dendritic cells, and an increased ratio of tumor‐infiltrating cytotoxic T cells against regulatory T cells are revealed in many studies, offering a glimpse into the mechanistic principles. Future advancements targeting different cancer checkpoints that could offer better immunosuppression coupled with other phototherapeutic strategies remain to be explored in accomplishing complete elimination of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378
A clearer vision for in vivo imaging
Weissleder, R. (2001) · Nature Biotechnology · doi:10.1038/86684 · Cited by 3,839
Immunogenic cell death and DAMPs in cancer therapy
Krysko, D. V., Garg, A. D., Kaczmarek, A., Krysko, O., Agostinis, P., & Vandenabeele, P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3380 · Cited by 3,223
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
Second window for in vivo imaging
Smith, A. M., Mancini, M. C., & Nie, S. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.326 · Cited by 2,848
Size and Temperature Dependence of the Plasmon Absorption of Colloidal Gold Nanoparticles
Link, S., & El-Sayed, M. A. (1999) · The Journal of Physical Chemistry B · doi:10.1021/jp984796o · Cited by 2,787
Functional Nanomaterials for Phototherapies of Cancer
Cheng, L., Wang, C., Feng, L., Yang, K., & Liu, Z. (2014) · Chemical Reviews · doi:10.1021/cr400532z · Cited by 2,425
CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition
Buchbinder, E. I., & Desai, A. (2016) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000239 · Cited by 2,360
Schadendorf, D., Hodi, F. S., Robert, C., Weber, J. S., Margolin, K., Hamid, O., Patt, D., Chen, T.-T., Berman, D. M., & Wolchok, J. D. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.2736 · Cited by 2,141
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I., Pashine, A., & Mellor, A. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1363 · Cited by 1,623
Chen, Q., Xu, L., Liang, C., Wang, C., Peng, R., & Liu, Z. (2016) · Nature Communications · doi:10.1038/ncomms13193 · Cited by 1,596
The role of apoptosis in response to photodynamic therapy: what, where, why, and how
Oleinick, N. L., Morris, R. L., & Belichenko, I. (2002) · Photochemical & Photobiological Sciences · doi:10.1039/b108586g · Cited by 1,503
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Fang, R. H., Hu, C.-M. J., Luk, B. T., Gao, W., Copp, J. A., Tai, Y., O’Connor, D. E., & Zhang, L. (2014) · Nano Letters · doi:10.1021/nl500618u · Cited by 1,501
Necroptosis: The Release of Damage-Associated Molecular Patterns and Its Physiological Relevance
Kaczmarek, A., Vandenabeele, P., & Krysko, D. V. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.003 · Cited by 1,411
ELSAYED, I., HUANG, X., & ELSAYED, M. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.07.035 · Cited by 1,354
Combination cancer immunotherapy and new immunomodulatory targets
Mahoney, K. M., Rennert, P. D., & Freeman, G. J. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4591 · Cited by 1,294
Fever and the thermal regulation of immunity: the immune system feels the heat
Evans, S. S., Repasky, E. A., & Fisher, D. T. (2015) · Nature Reviews Immunology · doi:10.1038/nri3843 · Cited by 1,257
Combination cancer immunotherapies tailored to the tumour microenvironment
Smyth, M. J., Ngiow, S. F., Ribas, A., & Teng, M. W. L. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.209 · Cited by 944
CTLA-4: new insights into its biological function and use in tumor immunotherapy
Egen, J. G., Kuhns, M. S., & Allison, J. P. (2002) · Nature Immunology · doi:10.1038/ni0702-611 · Cited by 940
Bode, C., Zhao, G., Steinhagen, F., Kinjo, T., & Klinman, D. M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.10.174 · Cited by 891
Mechanisms of pre‐apoptotic calreticulin exposure in immunogenic cell death
Panaretakis, T., Kepp, O., Brockmeier, U., Tesniere, A., Bjorklund, A., Chapman, D. C., Durchschlag, M., Joza, N., Pierron, G., van Endert, P., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.1 · Cited by 848
Nam, J., Son, S., Ochyl, L. J., Kuai, R., Schwendeman, A., & Moon, J. J. (2018) · Nature Communications · doi:10.1038/s41467-018-03473-9 · Cited by 808
PD-L1 expression in human cancers and its association with clinical outcomes
Yu, J., Wang, X., Teng, F., & Kong, L. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s105862 · Cited by 787
Oncolytic virus therapy: A new era of cancer treatment at dawn
Fukuhara, H., Ino, Y., & Todo, T. (2016) · Cancer Science · doi:10.1111/cas.13027 · Cited by 774
He, C., Duan, X., Guo, N., Chan, C., Poon, C., Weichselbaum, R. R., & Lin, W. (2016) · Nature Communications · doi:10.1038/ncomms12499 · Cited by 754
Regulatory T cells in cancer immunotherapy
Nishikawa, H., & Sakaguchi, S. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.12.005 · Cited by 705
Ding, X., Liow, C. H., Zhang, M., Huang, R., Li, C., Shen, H., Liu, M., Zou, Y., Gao, N., Zhang, Z., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja508641z · Cited by 701
Xu, J., Xu, L., Wang, C., Yang, R., Zhuang, Q., Han, X., Dong, Z., Zhu, W., Peng, R., & Liu, Z. (2017) · ACS Nano · doi:10.1021/acsnano.7b00715 · Cited by 695
Tumor Immunotherapy Directed at PD-1
Ribas, A. (2012) · New England Journal of Medicine · doi:10.1056/nejme1205943 · Cited by 683
Lan, G., Ni, K., Xu, Z., Veroneau, S. S., Song, Y., & Lin, W. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b01072 · Cited by 662
Blank, C., Gajewski, T. F., & Mackensen, A. (2005) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-004-0593-x · Cited by 637
Jiang, Y., Li, J., Zhen, X., Xie, C., & Pu, K. (2018) · Advanced Materials · doi:10.1002/adma.201705980 · Cited by 601
Self-citationWang, C., Xu, L., Liang, C., Xiang, J., Peng, R., & Liu, Z. (2014) · Advanced Materials · doi:10.1002/adma.201402996 · Cited by 566
An Update on Photodynamic Therapy Applications
Dougherty, T. J. (2002) · Journal of Clinical Laser Medicine & Surgery · doi:10.1089/104454702753474931 · Cited by 546
Guo, L., Yan, D. D., Yang, D., Li, Y., Wang, X., Zalewski, O., Yan, B., & Lu, W. (2014) · ACS Nano · doi:10.1021/nn5002112 · Cited by 532
Yuan, H., Fales, A. M., & Vo-Dinh, T. (2012) · Journal of the American Chemical Society · doi:10.1021/ja304180y · Cited by 523
Lu, K., He, C., Guo, N., Chan, C., Ni, K., Weichselbaum, R. R., & Lin, W. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b06663 · Cited by 505
Tsai, M.-F., Chang, S.-H. G., Cheng, F.-Y., Shanmugam, V., Cheng, Y.-S., Su, C.-H., & Yeh, C.-S. (2013) · ACS Nano · doi:10.1021/nn401187c · Cited by 480
Nanoparticle-Based Immunotherapy for Cancer
Shao, K., Singha, S., Clemente-Casares, X., Tsai, S., Yang, Y., & Santamaria, P. (2015) · ACS Nano · doi:10.1021/nn5062029 · Cited by 470
Li, J., Rao, J., & Pu, K. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.11.025 · Cited by 469
Self-citationDuan, X., Chan, C., Guo, N., Han, W., Weichselbaum, R. R., & Lin, W. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b09538 · Cited by 458
Recent Advances in Cancer Therapy: An Overview
Urruticoechea, A., Alemany, R., Balart, J., Villanueva, A., Vinals, F., & Capella, G. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210789941847 · Cited by 446
Henderson, T. A., & Morries, L. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s78182 · Cited by 430
Cai, Y., Liang, P., Tang, Q., Yang, X., Si, W., Huang, W., Zhang, Q., & Dong, X. (2017) · ACS Nano · doi:10.1021/acsnano.6b07927 · Cited by 422
Wang, D., Wang, T., Liu, J., Yu, H., Jiao, S., Feng, B., Zhou, F., Fu, Y., Yin, Q., Zhang, P., et al. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b01994 · Cited by 405
Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer
Huggett, M. T., Jermyn, M., Gillams, A., Illing, R., Mosse, S., Novelli, M., Kent, E., Bown, S. G., Hasan, T., Pogue, B. W., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.95 · Cited by 396
Li, J., Hu, Y., Yang, J., Wei, P., Sun, W., Shen, M., Zhang, G., & Shi, X. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.065 · Cited by 394
Self-citationA cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors
Wang, T., Wang, D., Yu, H., Feng, B., Zhou, F., Zhang, H., Zhou, L., Jiao, S., & Li, Y. (2018) · Nature Communications · doi:10.1038/s41467-018-03915-4 · Cited by 391
NIR photothermal therapy using polyaniline nanoparticles
Zhou, J., Lu, Z., Zhu, X., Wang, X., Liao, Y., Ma, Z., & Li, F. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.075 · Cited by 384
A melanin-mediated cancer immunotherapy patch
Ye, Y., Wang, C., Zhang, X., Hu, Q., Zhang, Y., Liu, Q., Wen, D., Milligan, J., Bellotti, A., Huang, L., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aan5692 · Cited by 381
CD20 deficiency in humans results in impaired T cell–independent antibody responses
Kuijpers, T. W., Bende, R. J., Baars, P. A., Grummels, A., Derks, I. A. M., Dolman, K. M., Beaumont, T., Tedder, T. F., van Noesel, C. J. M., Eldering, E., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40231 · Cited by 375
Peng, J., Xiao, Y., Li, W., Yang, Q., Tan, L., Jia, Y., Qu, Y., & Qian, Z. (2018) · Advanced Science · doi:10.1002/advs.201700891 · Cited by 364
Lyu, Y., Zeng, J., Jiang, Y., Zhen, X., Wang, T., Qiu, S., Lou, X., Gao, M., & Pu, K. (2018) · ACS Nano · doi:10.1021/acsnano.7b08616 · Cited by 357
Self-citationNanomaterials formulations for photothermal and photodynamic therapy of cancer
Shibu, E. S., Hamada, M., Murase, N., & Biju, V. (2013) · Journal of Photochemistry and Photobiology C: Photochemistry Reviews · doi:10.1016/j.jphotochemrev.2012.09.004 · Cited by 356
Zhen, X., Zhang, J., Huang, J., Xie, C., Miao, Q., & Pu, K. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201803321 · Cited by 352
Self-citationYuan, J., Gnjatic, S., Li, H., Powel, S., Gallardo, H. F., Ritter, E., Ku, G. Y., Jungbluth, A. A., Segal, N. H., Rasalan, T. S., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810114105 · Cited by 348
Oxygenic Hybrid Semiconducting Nanoparticles for Enhanced Photodynamic Therapy
Zhu, H., Li, J., Qi, X., Chen, P., & Pu, K. (2018) · Nano Letters · doi:10.1021/acs.nanolett.7b04759 · Cited by 333
Self-citationKenter, G. G., Welters, M. J. P., Valentijn, A. R. P. M., Löwik, M. J. G., Berends-van der Meer, D. M. A., Vloon, A. P. G., Drijfhout, J. W., Wafelman, A. R., Oostendorp, J., Fleuren, G. J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1881 · Cited by 315
Song, W., Kuang, J., Li, C.-X., Zhang, M., Zheng, D., Zeng, X., Liu, C., & Zhang, X.-Z. (2018) · ACS Nano · doi:10.1021/acsnano.7b09112 · Cited by 314
Antaris, A. L., Robinson, J. T., Yaghi, O. K., Hong, G., Diao, S., Luong, R., & Dai, H. (2013) · ACS Nano · doi:10.1021/nn4006472 · Cited by 310
Local tumour hyperthermia as immunotherapy for metastatic cancer
Toraya-Brown, S., & Fiering, S. (2014) · International Journal of Hyperthermia · doi:10.3109/02656736.2014.968640 · Cited by 302
Zhu, H., Cheng, P., Chen, P., & Pu, K. (2018) · Biomaterials Science · doi:10.1039/c7bm01210a · Cited by 297
Self-citationSemiconducting Polymer Nanoenzymes with Photothermic Activity for Enhanced Cancer Therapy
Li, J., Xie, C., Huang, J., Jiang, Y., Miao, Q., & Pu, K. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201800511 · Cited by 297
Self-citationZhen, X., Xie, C., & Pu, K. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201712550 · Cited by 284
Self-citationZhu, H., Fang, Y., Miao, Q., Qi, X., Ding, D., Chen, P., & Pu, K. (2017) · ACS Nano · doi:10.1021/acsnano.7b03507 · Cited by 270
Self-citationWhole Tumor Antigen Vaccines: Where Are We?
Chiang, C., Coukos, G., & Kandalaft, L. (2015) · Vaccines · doi:10.3390/vaccines3020344 · Cited by 269
Recent advances in different modal imaging-guided photothermal therapy
Chen, Q., Wen, J., Li, H., Xu, Y., Liu, F., & Sun, S. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.08.022 · Cited by 265
Stimulation of anti-tumor immunity by photodynamic therapy
Mroz, P., Hashmi, J. T., Huang, Y.-Y., Lange, N., & Hamblin, M. R. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.81 · Cited by 261
Li, B., Wang, Q., Zou, R., Liu, X., Xu, K., Li, W., & Hu, J. (2014) · Nanoscale · doi:10.1039/c3nr06242b · Cited by 259
Therapeutic hyperthermia: The old, the new, and the upcoming
Mallory, M., Gogineni, E., Jones, G. C., Greer, L., & Simone, C. B. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.08.003 · Cited by 258
Laser-photosensitizer assisted immunotherapy: a novel modality for cancer treatment
Chen, W. R., Adams, R. L., Carubelli, R., & Nordquist, R. E. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)04707-1 · Cited by 258
Generation of effective antitumor vaccines using photodynamic therapy.
Gollnick, S. O., Vaughan, L. A., & Henderson, B. W. (2002) · PubMed · Cited by 242
Gold nanoparticle mediated cancer immunotherapy
Almeida, J. P. M., Figueroa, E. R., & Drezek, R. A. (2014) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2013.09.011 · Cited by 236
Chen, T., Guo, J., Yang, M., Zhu, X., & Cao, X. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002991 · Cited by 227
Yata, T., Takahashi, Y., Tan, M., Nakatsuji, H., Ohtsuki, S., Murakami, T., Imahori, H., Umeki, Y., Shiomi, T., Takakura, Y., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.09.014 · Cited by 220
Semiconducting Photothermal Nanoagonist for Remote-Controlled Specific Cancer Therapy
Zhen, X., Xie, C., Jiang, Y., Ai, X., Xing, B., & Pu, K. (2018) · Nano Letters · doi:10.1021/acs.nanolett.7b05292 · Cited by 218
Self-citationIto, A., Tanaka, K., Kondo, K., Shinkai, M., Honda, H., Matsumoto, K., Saida, T., & Kobayashi, T. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01438.x · Cited by 216
Purification, Characterization, and Biosynthesis of Human Acid Ceramidase
Bernardo, K., Hurwitz, R., Zenk, T., Desnick, R. J., Ferlinz, K., Schuchman, E. H., & Sandhoff, K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.19.11098 · Cited by 214
Sato, K., Sato, N., Xu, B., Nakamura, Y., Nagaya, T., Choyke, P. L., Hasegawa, Y., & Kobayashi, H. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6843 · Cited by 213
Antitumor immunologically modified carbon nanotubes for photothermal therapy
Zhou, F., Wu, S., Song, S., Chen, W. R., Resasco, D. E., & Xing, D. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.12.029 · Cited by 203
Nanomedicine for Targeted Photothermal Cancer Therapy: Where are We Now?
Chen, F., & Cai, W. (2015) · Nanomedicine · doi:10.2217/nnm.14.186 · Cited by 197
Acid ceramidase and human disease
Park, J.-H., & Schuchman, E. H. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.08.019 · Cited by 195
Toraya-Brown, S., Sheen, M. R., Zhang, P., Chen, L., Baird, J. R., Demidenko, E., Turk, M. J., Hoopes, P. J., Conejo-Garcia, J. R., & Fiering, S. (2014) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2014.01.011 · Cited by 193
Dai, L., Li, K., Li, M., Zhao, X., Luo, Z., Lu, L., Luo, Y., & Cai, K. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201707249 · Cited by 193
Yu, X., Gao, D., Gao, L., Lai, J., Zhang, C., Zhao, Y., Zhong, L., Jia, B., Wang, F., Chen, X., et al. (2017) · ACS Nano · doi:10.1021/acsnano.7b04736 · Cited by 192
Chen, W. (2011) · Nature Immunology · doi:10.1038/ni.2088 · Cited by 182
Synthetic immune niches for cancer immunotherapy
Weiden, J., Tel, J., & Figdor, C. G. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.89 · Cited by 174
Pan, J., Wang, Y., Zhang, C., Wang, X., Wang, H., Wang, J., Yuan, Y., Wang, X., Zhang, X., Yu, C., et al. (2018) · Advanced Materials · doi:10.1002/adma.201704408 · Cited by 174
Overexpression of Acid Ceramidase Protects from Tumor Necrosis Factor–Induced Cell Death
Strelow, A., Bernardo, K., Adam-Klages, S., Linke, T., Sandhoff, K., Krönke, M., & Adam, D. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.601 · Cited by 172
Jiang, Y., Cui, D., Fang, Y., Zhen, X., Upputuri, P. K., Pramanik, M., Ding, D., & Pu, K. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.08.037 · Cited by 166
Self-citationTargeted cancer imaging and photothermal therapy via monosaccharide-imprinted gold nanorods
Yin, D., Li, X., Ma, Y., & Liu, Z. (2017) · Chemical Communications · doi:10.1039/c7cc02247f · Cited by 164
Banchereau, J., & Palucka, K. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.149 · Cited by 154
Photodynamic Therapy of Tumors Can Lead to Development of Systemic Antigen-Specific Immune Response
Mróz, P., Szokalska, A., Wu, M. X., & Hamblin, M. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015194 · Cited by 153
Li, L., Liu, Y. L., Hao, P., Wang, Z., Fu, L., Ma, Z., & Zhou, J. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.075 · Cited by 148
Cano‐Mejia, J., Burga, R. A., Sweeney, E. E., Fisher, J. P., Bollard, C. M., Sandler, A. D., Cruz, C. C., & Fernandes, R. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.10.015 · Cited by 148
Blocking IDO activity to enhance anti-tumor immunity
Munn, D. H. (2012) · Frontiers in Bioscience-Elite · doi:10.2741/e414 · Cited by 146
Liu, Y., Maccarini, P. F., Palmer, G. M., Etienne, W., Zhao, Y., Lee, C.-T., Ma, X., Inman, B. A., & Vo‐Dinh, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-09116-1 · Cited by 144
Tao, Y., Ju, E., Liu, Z., Dong, K., Ren, J., & Qu, X. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.073 · Cited by 143
Ostberg, J. R., Dayanç, B. E., Yuan, M., Oflazoglu, E., & Repasky, E. A. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1106699 · Cited by 138
The market for chimeric antigen receptor T cell therapies
Yip, A., & Webster, R. M. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.266 · Cited by 137
Immunogenic Apoptosis as a Novel Tool for Anticancer Vaccine Development
Montico, B., Nigro, A., Casolaro, V., & Col, J. D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020594 · Cited by 134
Panzarini, E., Inguscio, V., Fimia, G. M., & Dini, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105778 · Cited by 132
Clinical effects of in situ photoimmunotherapy on late-stage melanoma patients
Li, X., Naylor, M. F., Le, H., Nordquist, R. E., Teague, T. K., Howard, C. A., Murray, C. K., & Chen, W. R. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.11.13434 · Cited by 131
Overview of Tumor Cell–Based Vaccines
Copier, J. P., & Dalgleish, A. G. (2006) · International Reviews of Immunology · doi:10.1080/08830180600992472 · Cited by 126
Li, L., Yang, S., Song, L., Zeng, Y., He, T., Wang, N., Yu, C., Yin, T., Liu, L., Wei, X., et al. (2017) · Theranostics · doi:10.7150/thno.19826 · Cited by 122
Prussian blue nanoparticles for laser-induced photothermal therapy of tumors
Hoffman, H. A., Chakrabarti, L., Dumont, M., Sandler, A. D., & Fernandes, R. (2014) · RSC Advances · doi:10.1039/c4ra05209a · Cited by 120
Photodynamic-Immune Checkpoint Therapy Eradicates Local and Distant Tumors by CD8+ T Cells
Kleinovink, J. W., Fransen, M. F., Löwik, C. W. G. M., & OSSENDORP, F. A. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0055 · Cited by 119
Photodynamic therapy-generated vaccine for cancer therapy
Korbelik, M., & Sun, J. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0088-4 · Cited by 117
Monoclonal Antibody "Gold Rush"
Maggon, K. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707781368504 · Cited by 116
Blocking IDO activity to enhance anti-tumor immunity
David, H. M. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/414 · Cited by 116
Kleinovink, J. W., van Driel, P. B., Snoeks, T. J. A., Prokopi, N., Fransen, M. F., Cruz, L. J., Mezzanotte, L., Chan, A. B., Löwik, C. W. G. M., & OSSENDORP, F. A. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0515 · Cited by 115
Combinatorial immunotherapy and nanoparticle mediated hyperthermia
Moy, A. J., & Tunnell, J. W. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.06.008 · Cited by 114
Li, W., Rong, P., Yang, K., Huang, P., Sun, K., & Chen, X. S. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.12.037 · Cited by 112
Gao, L., Zhang, C., Gao, D., Liu, H., Yu, X., Lai, J., Wang, F., Lin, J., & Liu, Z. (2016) · Theranostics · doi:10.7150/thno.14792 · Cited by 112
Advanced smart-photosensitizers for more effective cancer treatment
Park, W., Cho, S., Han, J., Shin, H., Na, K., Lee, B., & Kim, D. (2017) · Biomaterials Science · doi:10.1039/c7bm00872d · Cited by 112
CpG Oligodeoxyneucleotides as TLR9 Agonists: Therapeutic Applications in Cancer
Murad, Y. M., & Clay, T. M. (2009) · BioDrugs · doi:10.2165/11316930-000000000-00000 · Cited by 110
Kang, X., Guo, X., Niu, X., An, W., Li, S., Liu, Z., Yang, Y., Wang, N., Jiang, Q., Yan, M., et al. (2017) · Scientific Reports · doi:10.1038/srep42069 · Cited by 106
Chen, C., Kuo, L.-R., Chang, C.-L., Hwu, Y., Huang, C.-K., Lee, S., Chen, K., Lin, S.-J., Huang, J., & Chen, Y. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.140 · Cited by 104
Photodynamic therapy-generated vaccines: relevance of tumour cell death expression
Korbelik, M., Stott, B., & Sun, J. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604059 · Cited by 99
The perfect personalized cancer therapy: cancer vaccines against neoantigens
Aurisicchio, L., Pallocca, M., Ciliberto, G., & Palombo, F. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0751-1 · Cited by 97
Zheng, Y., Yin, G., Le, V., Zhang, A., Chen, S., Liang, X., & Liu, J. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.12852 · Cited by 95
In situ photoimmunotherapy: a tumour-directed treatment for melanoma
Naylor, M. F., Chen, W. R., Teague, T. K., Perry, L., & Nordquist, R. E. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07514.x · Cited by 94
Tian, Y., Zhang, J., Tang, S., Zhou, L., & Yang, W. (2015) · Small · doi:10.1002/smll.201503319 · Cited by 94
Tryptophan Catabolism and Cancer Immunotherapy Targeting IDO Mediated Immune Suppression
Amobi, A. E., Qian, F., Lugade, A. A., & Odunsi, K. O. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-67577-0_9 · Cited by 90
Wang, S., Ma, X., Hong, X., Cheng, Y., Tian, Y., Zhao, S., Liu, W., Tang, Y., Zhao, R., Song, L., et al. (2017) · ACS Nano · doi:10.1021/acsnano.7b07757 · Cited by 86
Zhou, F., Li, X., Naylor, M. F., Hode, T., Nordquist, R. E., Alleruzzo, L., Raker, J., Lam, S. S. K., Du, N., Shi, L., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.01.029 · Cited by 82
Liu, X., Cheng, J., Turner, L. S., Elojeimy, S. N., Beckham, T. H., Bielawska, A. E., Keane, T. E., Hannun, Y. A., & Norris, J. S. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903357512 · Cited by 79
Cancer vaccines generated by photodynamic therapy
Korbelik, M. (2011) · Photochemical & Photobiological Sciences · doi:10.1039/c0pp00343c · Cited by 77
Near‐infrared photoimmunotherapy targeting EGFR—Shedding new light on glioblastoma treatment
Burley, T. A., Mączyńska, J., Shah, A., Szopa, W., Harrington, K. J., Boult, J. K. R., Mrozek‐Wilczkiewicz, A., Vinci, M., Bamber, J. C., Kaspera, W., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31246 · Cited by 73
Identification of calreticulin as a marker for phagocytosis of apoptotic cells in Drosophila
Kuraishi, T., Manaka, J., Kono, M., Ishii, H., Yamamoto, N., Koizumi, K., Shiratsuchi, A., Lee, B. L., Higashida, H., & Nakanishi, Y. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.10.027 · Cited by 69
Enhancement of laser cancer treatment by a chitosan-derived immunoadjuvant
Chen, W. R., Korbelik, M., Bartels, K. E., Liu, H., Sun, J., & Nordquist, R. E. (2004) · Photochemistry and Photobiology · doi:10.1562/2004-07-20-ra-236 · Cited by 69
Rahimian, S., Kleinovink, J. W., Fransen, M. F., Mezzanotte, L., Gold, H., Wisse, P., Overkleeft, H. S., Amidi, M., Jiskoot, W., Löwik, C. W. G. M., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.043 · Cited by 67
Kumar, P., & Srivastava, R. (2015) · Materials Science and Engineering C · doi:10.1016/j.msec.2015.08.006 · Cited by 66
Korbelik, M., Banáth, J. P., Saw, K. M., Zhang, W., & ÄŒiplys, E. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00015 · Cited by 61
Xia, Y., Gupta, G. K., Castaño, A. P., Mróz, P., Avci, P., & Hamblin, M. R. (2013) · Journal of Biophotonics · doi:10.1002/jbio.201300072 · Cited by 59
Various ways to improve whole cancer cell vaccines
Cicchelero, L., de Rooster, H., & Sanders, N. N. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.911093 · Cited by 56
Andersson, H., Kim, Y.-S., O’Neill, B. E., Shi, Z.-Z., & Serda, R. E. (2014) · Vaccines · doi:10.3390/vaccines2020216 · Cited by 46
Xue, P., Sun, L., Li, Q., Zhang, L., Xu, Z., Li, C. M., & Kang, Y. (2017) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2017.09.027 · Cited by 40
Bae, S., Kim, Y., Kwak, S., Kim, Y., Ro, D., Shin, J., Park, C., Han, S., Oh, C., Kim, C., et al. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00447.x · Cited by 36
Oh, D. S., Kim, H., Oh, J. E., Jung, H. E., Lee, Y. S., Park, J., & Lee, H. K. (2017) · Oncotarget · doi:10.18632/oncotarget.17663 · Cited by 33
Imageable Antigen‐Presenting Gold Nanoparticle Vaccines for Effective Cancer Immunotherapy In Vivo
Lee, I., Kwon, H., An, S., Kim, D., Kim, S., Yu, M. K., Lee, J., Lee, T. S., Im, S., & Jon, S. (2012) · Angewandte Chemie · doi:10.1002/ange.201203193 · Cited by 31
The emergence of acid ceramidase as a therapeutic target for acute myeloid leukemia
Tan, S., Pearson, J. M., Feith, D. J., & Loughran, T. P. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1322065 · Cited by 30
Anti-tumor immunity of BAM-SiPc-mediated vascular photodynamic therapy in a BALB/c mouse model
Yeung, H., Lo, P., Ng, D. K. P., & Fong, W. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.84 · Cited by 26
Korbelik, M., Banáth, J. P., Zhang, W., Saw, K. M., Szulc, Z. M., Bielawska, A. E., & Šeparović, D. (2016) · International Journal of Cancer · doi:10.1002/ijc.30171 · Cited by 26
Zheng, Y., Zou, F., Wang, J., Yin, G., Le, V., Fei, Z., & Liu, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.624965 · Cited by 24
Korbelik, M., & Merchant, S. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1206-8 · Cited by 23
Korbelik, M., Banáth, J. P., & Zhang, W. (2016) · Cancers · doi:10.3390/cancers8100094 · Cited by 20
Calreticulin is an effective immunologic adjuvant to tumor-associated antigens
Wang, J., Gao, Z., Qin, S., Liu, C. B., & Zou, L. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4989 · Cited by 20
Photosensitizer-induced self-assembly of antigens as nanovaccines for cancer immunotherapy
Cao, F., Yan, M. M., Liu, Y. J., Liu, L. X., Li, L., Wang, H., Zhang, C., Sun, H., Kong, D., & Ma, G. L. (2018) · Biomaterials Science · doi:10.1039/c7bm01082f · Cited by 19
Long peptide-based cancer immunotherapy targeting tumor antigen-specific CD4+and CD8+T cells
Tomita, Y., & Nishimura, Y. (2013) · OncoImmunology · doi:10.4161/onci.25801 · Cited by 13
Zhang, L., Chen, J., Song, X., Wen, W., Li, Y., Zhang, Y. X., & Yin, Y. (2014) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504014x13887748696789 · Cited by 8
Cited by
Clinical development and potential of photothermal and photodynamic therapies for cancer
Li, X., Lovell, J. F., Yoon, J., & Chen, X. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0410-2 · Cited by 3,456
Second near-infrared photothermal materials for combinational nanotheranostics
Xu, C., & Pu, K. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00664e · Cited by 941
Self-citationEmerging photothermal-derived multimodal synergistic therapy in combating bacterial infections
Huo, J., Jia, Q., Huang, H., Zhang, J., Li, P., Dong, X., & Huang, W. (2021) · Chemical Society Reviews · doi:10.1039/d1cs00074h · Cited by 847
Photodynamic Therapy—Current Limitations and Novel Approaches
Gunaydin, G., Gedik, M. E., & Ayan, S. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.691697 · Cited by 599
Immune Cell Membrane‐Coated Biomimetic Nanoparticles for Targeted Cancer Therapy
Oroojalian, F., Beygi, M., Baradaran, B., Mokhtarzadeh, A., & Shahbazi, M. (2021) · Small · doi:10.1002/smll.202006484 · Cited by 528
Metadata
- Authors
- Ng, C. W., Li, J., & Pu, K.
- Venue
- Advanced Functional Materials
- Publisher
- Wiley
- Published
- 2018-09-20
- Volume
- 28
- Issue
- 46
- ISSN
- 1616-301X (ISSN-L)
- 1616-3028
- OpenAlex
- W2890587360
- Cited by
- 349
- References
- 154
- FWCI
- 15.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.